Published in Contrib Nephrol on January 01, 2001
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int (2011) 2.15
Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol (2006) 1.83
NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J Am Soc Nephrol (2009) 1.80
Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney. Am J Pathol (2005) 1.63
Mechanisms of progression of chronic kidney disease. Pediatr Nephrol (2007) 1.52
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest (2003) 1.42
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis. Am J Pathol (2005) 1.16
A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J Clin Invest (2013) 1.16
Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol (2009) 1.07
RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species. Am J Physiol Renal Physiol (2014) 1.02
Combining angiotensin II blockade and renin receptor inhibition results in enhanced antifibrotic effect in experimental nephritis. Am J Physiol Renal Physiol (2011) 0.84
Circulating TGF-beta1 as a reliable biomarker for chronic kidney disease progression in the African-American population. Kidney Int (2009) 0.82
Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. Med Sci Monit (2011) 0.82
Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease. Pediatr Nephrol (2010) 0.81
Effects of 1-year administration of olmesartan on portal pressure and TGF-beta1 in selected patients with cirrhosis: a randomized controlled trial. J Gastroenterol (2011) 0.78
Effect of Shenkang granules on the progression of chronic renal failure in 5/6 nephrectomized rats. Exp Ther Med (2015) 0.78
Grape seed extract attenuates arsenic-induced nephrotoxicity in rats. Exp Ther Med (2013) 0.76
Differentiating Glomerular Inflammation from Fibrosis in a Bone Marrow Chimera for Rat Anti-Glomerular Basement Membrane Glomerulonephritis. Am J Nephrol (2015) 0.75
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature (1992) 3.96
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet (2000) 3.64
Proposal for a classification of oocytes and follicles in the mouse ovary. J Reprod Fertil (1968) 3.38
Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet (1999) 3.24
Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci U S A (1993) 3.16
Antagonistic interactions between FGF and BMP signaling pathways: a mechanism for positioning the sites of tooth formation. Cell (1997) 3.08
Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet (2000) 3.06
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther (2014) 2.88
Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int (2006) 2.85
Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest (1994) 2.81
Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest (1990) 2.56
Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst (2001) 2.44
Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet (2001) 2.43
Antitubular basement-membrane antibodies in methicillin-associated interstitial nephritis. N Engl J Med (1974) 2.20
Nehprotic syndrome with glomerular mesangial IgM deposits. Lab Invest (1978) 2.19
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
The development of the mouse ovary from birth to maturity. Acta Endocrinol (Copenh) (1969) 2.02
TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int (1997) 2.01
Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med (1996) 1.93
Kidney size in childhood. Sonographical growth charts for kidney length and volume. Pediatr Radiol (1985) 1.92
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension (1998) 1.90
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest (1995) 1.79
Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int (2007) 1.76
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int (1999) 1.76
Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int (1994) 1.70
Hepatitis B in chronic kidney disease: moving toward effective prevention. Kidney Int (2008) 1.66
Detection of circulating immune complexes in patients with glomerulonephritis. Kidney Int (1977) 1.66
Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum (1980) 1.56
Identification of the putative mammalian orthologue of Sec31P, a component of the COPII coat. J Cell Sci (1999) 1.42
[Passive smoking. Concentrations of smoke constituents in the air of large and small rooms as a function of number of cigarettes smoked and time]. Int Arch Arbeitsmed (1972) 1.41
A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. J Thorac Cardiovasc Surg (1996) 1.41
Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.40
[What is the recurrence rate for Basedow's disease treated with thyrostatic agents. Answers from a prospective study]. Schweiz Med Wochenschr (1990) 1.39
Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells (2005) 1.38
Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet (1998) 1.35
Origin of follicle cells in the infant mouse ovary. Fertil Steril (1967) 1.34
Enzyme-linked immunosorbent assay for detection of T-2 toxin. Hoppe Seylers Z Physiol Chem (1982) 1.33
The gene for cherubism maps to chromosome 4p16. Am J Hum Genet (1999) 1.32
Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int (1992) 1.32
VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab (2006) 1.29
Charge-related alterations of the cerebral endothelium. Lab Invest (1983) 1.27
Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab Invest (1991) 1.25
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay. Med Microbiol Immunol (1993) 1.25
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data. Oncogene (2007) 1.24
Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest (1984) 1.24
IgA antibasement membrane nephritis with pulmonary hemorrhage. Ann Intern Med (1979) 1.22
Targeted disruption of Pax1 defines its null phenotype and proves haploinsufficiency. Proc Natl Acad Sci U S A (1998) 1.22
Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int (1992) 1.21
Increased expression of transforming growth factor beta isoforms (beta 1, beta 2, beta 3) in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol (1995) 1.21
Migration of gonocytes into the mammalian gonad and their differentiation. Philos Trans R Soc Lond B Biol Sci (1970) 1.19
Follicular growth: the basic event in the mouse and human ovary. J Reprod Fertil (1975) 1.19
Coordinated expression of beta 1 integrins and transforming growth factor-beta-induced matrix proteins in glomerulonephritis. Lab Invest (1993) 1.18
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade. Kidney Int (1998) 1.18
Clinical findings and biochemical and molecular analysis of four patients with holocarboxylase synthetase deficiency. Am J Med Genet (2002) 1.17
Molecular characterization of Pax6(2Neu) through Pax6(10Neu): an extension of the Pax6 allelic series and the identification of two possible hypomorph alleles in the mouse Mus musculus. Genetics (2001) 1.13
Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives. Aliment Pharmacol Ther (2006) 1.11
Immunocytochemical localization of enterobacterial common antigen in Escherichia coli and Yersinia enterocolitica cells. J Bacteriol (1986) 1.07
Morphological study of the ovaries of leukaemic children. Br J Cancer (1978) 1.07
[Entrustable professional activities in the internship]. Chirurg (2014) 1.07
Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma. J Pathol (1993) 1.07
A randomized trial to develop criteria for administering erythrocyte transfusions to anemic preterm infants 1 to 3 months of age. J Perinatol (1989) 1.06
Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy. Kidney Int (1998) 1.06
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy. Kidney Int (1990) 1.05
Follicular development in the infant human ovary. J Reprod Fertil (1974) 1.05
Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet (2004) 1.05
Targeting TGF-beta for treatment of disease. Nat Med (1995) 1.03
Sigma factor displacement from RNA polymerase during Bacillus subtilis sporulation. J Bacteriol (1999) 1.03
Developmental expression of Pax1/9 genes in urochordate and hemichordate gills: insight into function and evolution of the pharyngeal epithelium. Development (1999) 1.03
Renal damage with intestinal bypass. Ann Intern Med (1978) 1.02
Integrins. Kidney Int Suppl (1994) 1.02
Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol (1998) 1.01
Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int (1997) 1.01
Follicular growth in fetal and prepubertal ovaries of humans and other primates. Clin Endocrinol Metab (1978) 1.00
In vivo interactions of TGF-beta and extracellular matrix. Prog Growth Factor Res (1992) 1.00
Antigenic changes as a determinant of immune complex localization in the rat glomerulus. Lab Invest (1981) 1.00
RNA synthesis in the mouse oocyte. J Cell Biol (1974) 0.99
Influence of irradiation and chemotherapy on the ovaries of children with abdominal tumours. Br J Cancer (1977) 0.99
Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int (1999) 0.99
Failure of heparin to affect two types of experimental glomerulonephritis in rabbits. Kidney Int (1975) 0.99
Hypoxia in a human intracerebral glioma model. J Neurosurg (2000) 0.99